asthma - International Pharmaceutical Industry

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

News

New asthma drug approved on NHS branded a ‘wonder drug’

NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma. Dupilumab (also known as Dupixe...

20 October 2021 News asthma | drug

Continue Reading →

Volume 13 Issue 3

Smart Inhalers: A Digital Step Towards Patient-Centricity

Respiratory infections continue to have the highest incidence rate in Europe. Where asthma is considered, there has been a sharp increase in global cases, morbidity,...

13 September 2021 Volume 13 Issue 3 asthma | H&T Presspart

Continue Reading →

Volume 13 Issue 3

New DPI Data Insights Shaping Future of Global Healthcare Needs

Innovative inhalation therapies and drug delivery are legacies of the COVID-19 pandemic, as pharma and biopharma formulators address growing demands for new healthca...